Coriolis Pharma joins LyoHUB

Coriolis Pharma Joins LyoHUB to Drive Lyophilization Innovation

Coriolis Pharma is proud to join LyoHUB, the Advanced Lyophilization Technology Consortium. This collaboration highlights our commitment to advancing freeze-drying technologies through scientific exchange and cross-sector partnerships.

About LyoHUB

Founded in 2014 at Purdue University, LyoHUB is a precompetitive consortium dedicated to transforming lyophilization (freeze-drying) in pharmaceutical and biotech manufacturing. It brings together academia, industry leaders, and technology developers to accelerate innovation, improve product quality, and reduce manufacturing timelines and costs.

Members include leading pharmaceutical companies (e.g., Pfizer, Merck, AstraZeneca, Roche), freeze-dryer manufacturers (Millrock Technology, IMA LIFE, ATS, RheaVita), and primary packaging providers (West Pharmaceutical Services, Stevanato Group, Corning).

Coriolis Pharma’s Contribution

Coriolis Pharma will actively contribute to LyoHUB’s working groups, educational initiatives, and collaborative research. The company will share insights from its science-driven formulation and lyophilized drug product development expertise, support the development of best practices, and help shape the future of pharmaceutical manufacturing through the Lyo2040 Technology Roadmap.